Maelstrom Research Staging | RECOVER_Phase_1_COVID19_group_RECOVER_Phase_1_COVID19_group_Followup_546

RECOVER_Phase_1_COVID19_group_RECOVER_Phase_1_COVID19_group_Followup_546_days

Networks -

Variables -

Associated study RECOVER Contingency Table

Population

RECOVER - Phase 1 COVID-19 group

The population is composed of healthcare workers that have tested positive for COVID-19 and that, upon initial infection, are symptomatic or not.

Selection Criteria

Newborns

Twins

Countries

Canada

Territory

Ethnic Origin

Health Status

Participants must have had a PCR-confirmed COVID-19 infection prior to enrollment.

Other Criteria

Exclusion criteria:

At the time of recruitment are no longer working in a healthcare setting or have been furloughed as a preventive measure;

Are not fluent in French or English;

Have no access to a cell phone or internet, as follow-up will be done through text messages and emails.

Are participating in a clinical trial for preventive treatment of COVID-19 {e.g., high dose Vitamin D (>2000IU/day or ≥10,000IU/wk), colchicine}, who are still on treatment upon recruitment. Can be included if taken for other reasons.

Have received a COVID-19 vaccine prior to their enrolment in the study.

Supplementary Information about selection criteria

Of 570 participants, the majority are female (83.0%) and Caucasian (79.3%). The median age is 42. Most worked in acute-care hospitals (54.1%) or public long-term care facilities (24.4%). The most commonly reported profession is nurse/paramedic (40.4%), followed by patient care attendant (12.8%) and physician/medical resident (11.8%).

Recruitment

Sources of recruitment

Specific population
Participants from existing studies

Specific Population

Members of an association

Supplementary Information

Recruitment is done in vaccine study centers (MUHC/CHUSJ Vaccine Center), with additional recruitment in hospitals (CHUM, JGH, MUHC) or CHSLDs, near/where participants work.

Participants are also recruited from the large case-control study conducted by the INSPQ.

Participants from Existing Studies

Santé Publique du Québec (INSPQ) (G. De Serres) case-control study

Number of Participants

Number of Participants: 570
Number of Participants with Biological Samples: 570

More info

Data Collection Event

RECOVER - Phase 1 COVID-19 group - Follow-up 18 months

Information is collected from unvaccinated participants about changes in the workplace or work duties, changes in residual symptoms, new influenza-like illnesses, new medical conditions, new medication, and new vitamin intake. Blood samples are collected from unvaccinated participants.

More info

Collected Dataset / RECOVER_Phase_1_COVID19_group_RECOVER_Phase_1_COVID19_group_Followup_546_days

RECOVER_Phase_1_COVID19_group_RECOVER_Phase_1_COVID19_group_Followup_546_days

Population

RECOVER - Phase 1 COVID-19 group

Data Collection Event

RECOVER - Phase 1 COVID-19 group - Follow-up 18 months

Files

Variables Classifications